It is estimated than one out of 3 people in Spain will suffer of cancer along the life. In fact cancer is responsible for the 25% of deaths in our country. The good news is that the overall survival at five years is around 66%. For the future it will be necessary to review the way we are developing clinical trials in order to approve the drugs by the regulatory agencies. Other important topics is how to approach the long survivor and also the economic issues related to it. In addition it will be also critical to establish the adequate policy for the prevention of cancer (primary and secondary) including the early diagnosis, the screening and the genetic counsel.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Insight of Intestinal Fatty Acid Binding Protein as a Potential Biomarker in the Biology of Epithelial Damage of Gastrointestinal Membrane.
Curr Protein Pept Sci
January 2025
Department of Biotechnology, Motilal Nehru National Institute of Technology Allahabad (MNNITA), Allahabad, India.
The diagnosis of intestinal injury remains a challenge as it is rare in occurrence and transpires in multiple traumatized patients. The deferred finding of injury of intestines upsurges multiple risks such as septicemia, numerous organ failures as well as mortality. In this review, we corroborate with the goals of proposing surrogate biomarkers that consent to the measurement of the permeability of intestines more effortlessly.
View Article and Find Full Text PDFEmerging Threats and Challenges of Monkeypox Virus: Exploration and Sensitivity.
Curr Drug Targets
January 2025
Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, U.P., India.
Updates on Recent Advances in the Therapy of Adult Psoriatic Disease.
Curr Rheumatol Rev
January 2025
University of Toronto, Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada.
Psoriatic arthritis (PsA) is a heterogeneous inflammatory disease with various joint and skin manifestations and multiple associated comorbidities. The management of PsA is important not only in controlling disease activity and preventing subsequent damage but also in improving the quality of life and reducing mortality. Over the years, numerous drugs have been introduced into the therapeutic armamentarium of the disease.
View Article and Find Full Text PDFThe Presence of Nitrosamines and Nitrosamine Drug-Related Substances in Pharmaceutical Products: An Overview of Regulatory Concerns, Analytical Methodologies, and Control Strategies.
Curr Drug Saf
January 2025
Department of Chemistry, K J Somaiya College of Science and Commerce, Vidyavihar, Mumbai-77, India.
The presence of N-nitrosamine impurities in pharmaceutical products is well known. In 2019, it resulted in drug recall by the Food and Drug Administration (FDA). Soon, several groups identified the presence of many N-nitrosamines (NAs) in various Active Pharmaceutical Ingredients (APIs) and drug formulations worldwide.
View Article and Find Full Text PDFCAR-T Cell Therapy: Pioneering Immunotherapy Paradigms in Cancer Treatment.
Curr Pharm Biotechnol
January 2025
Department of Pharmacology, School of Pharmacy & Technology Management, SVKM's NMIMS Deemed to-be University, Shirpur - 425405, India.
The world's one of the major causes of death are cancer. Cancer is still a complex disease over the years that needs to be cured. Traditional cytotoxic approaches, although they have been implemented for years for treating neoplastic diseases, yet are limited due to the intricacy and low efficiency of cancer cells.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!